Glenmark Generics announced that its US subsidiary received ANDA approval from US FDA for Betamethasone Dipropionate Cream, 0.05% and stated that it would soon commence marketing and distribution of this product in the US market.
Betamethasone Dipropionate is high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
For comments and feedback: editorial@rttnews.com